The ZS Approach
ZS is a global consulting firm with nearly 5,000 strategy, analytics and technology experts. We’ve worked with pharmaceutical clients for more than 30 years, and while we apply that experience to each new project, we take the time to learn your organization’s unique questions and challenges, and to build customized solutions. Then we’ll work with you to develop a strategy and to execute it.
Commercial forecasting: We’ll guide you in assessing a drug’s commercial viability, taking into account variables such as the addressable population and its characteristics, benefits provided and price sensitivities. We marshal our deep knowledge of pharmaceutical products, problem-solving capabilities and forecasting techniques to develop robust commercial forecasts for new and existing products.
Market access: ZS develops scenarios describing possible combinations of market access and pricing connected to a specific clinical development strategy, allowing you to accurately assess a product’s profit potential.
Product development strategy: Our experts will partner with you to determine which product indications to develop and in what order, considering each indication’s feasibility, how to gather and provide evidence for the indications’ value stories, and how quickly the product could proceed to trial.
Hands-On Product Development
Our goal is to help you improve the efficiency of your drug development and commercialization processes, thereby improving your business’s profitability. We combine strategy, technology and deep expertise to help solve your organization’s problems. We take a hands-on, collaborative approach to each project, partnering with you to develop effective plans and then working side by side with you to execute them.
How Good Market Access Strategies Boost New Product Launches
>READ THE ZS INTERVIEW
ZS Oncology Watchdog Report: Biosimilars in Therapeutic Oncology
>DOWNLOAD THE REPORT